Antiviral composition containing glucosan
A dextran and anti-virus technology, which is applied in the direction of disinfectant, biocide, animal repellent, etc., can solve the problems that the compounding technology of dextran and component A has not been reported, and achieve the goal of field application The effect of reducing quantity, reducing single selection pressure, and reducing cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] 11% dextran · Component A emulsifiable concentrate
[0033] Raw material composition: 1% dextran sugar, 10% component A technical drug, 5% N-methylpyrrolidone, 3% calcium dodecylbenzenesulfonate, 2% fatty alcohol ether sodium sulfate phosphate, 5% benzene Ethylphenol formaldehyde resin polyoxyethylene ether, and the rest is made up with aromatic hydrocarbon S-150. Prepared according to the conventional cream production method. The component A is (1S,3S)-N'-(4-chlorophenylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b ] indole-3-carboxyl hydrazide.
[0034] Example 1 sample, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: Tobacco mosaic disease, tomato virus disease.
[0035]
[0036] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the anti-bacterial ...
Embodiment 2
[0038] 30% Dextran · Component A Suspending Concentrate
[0039] The raw material composition is: 20% dextran, 10% component A, 1% sodium lignin sulfate, 2% calcium dodecylbenzenesulfonate, 3% tristyryl phenol polyoxyethylene ether, fatty alcohol 1.0% polyoxyethylene ether, 1% magnesium aluminum silicate, 0.10% xanthan gum, 5% ethylene glycol, and make up the rest with water. Prepared according to the conventional production method of suspension concentrate. The component A is (1S,3S)-N'-(cyclohexylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indole -3-Formohydrazide.
[0040] The sample of Example 2, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: cucumber mosaic disease, potato shrunken mosaic disease.
[0041]
[0042] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The da...
Embodiment 3
[0044] 41% dextran · component A wettable powder
[0045] The raw material composition is 1% dextran, 40% component A, 1% sodium lauryl sulfate, 7% sodium alkylphenol ethoxylate sulfonate, 2% sodium lignosulfonate, 3.5% lignin Sulfonate dispersant, the rest is supplemented with light calcium carbonate. Formulated according to conventional wettable powder production methods. The component A is (1S,3S)-N'-(cyclohexylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indole -3-Formohydrazide.
[0046] The sample of Example 3, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: turnip mosaic disease, potato shrunken mosaic disease.
[0047]
[0048] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the anti-bacterial efficiency of the compound preparation is improved com...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com